Georgetown University Hospital /ID# 1128-0824 — Washington D.C., District of Columbia

Georgetown University Hospital /ID# 1128-0824 is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Georgetown University Hospital /ID# 1128-0824 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Advanced Gastric Adenocarcinoma.

Sponsors: Pharmacyclics LLC..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown University Hospital /ID# 1128-0824?

Georgetown University Hospital /ID# 1128-0824 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown University Hospital /ID# 1128-0824 conducted?

Georgetown University Hospital /ID# 1128-0824 has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Advanced Gastric Adenocarcinoma.

Is Georgetown University Hospital /ID# 1128-0824 accredited by Crixeo Health?

Georgetown University Hospital /ID# 1128-0824 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown University Hospital /ID# 1128-0824?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.